PERNIX THERAPEUTICS HLDGS IN's ticker is PTX and the CUSIP is 71426V108. A total of 114 filers reported holding PERNIX THERAPEUTICS HLDGS IN in Q2 2015. The put-call ratio across all filers is 686.00 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2016 | $169,000 | -63.5% | 160,880 | +2.5% | 0.00% | -100.0% |
| Q4 2015 | $463,000 | -6.5% | 156,940 | +0.3% | 0.00% | 0.0% |
| Q3 2015 | $495,000 | -47.8% | 156,541 | -2.2% | 0.00% | 0.0% |
| Q2 2015 | $948,000 | -8.1% | 160,074 | +66.0% | 0.00% | 0.0% |
| Q1 2015 | $1,031,000 | +14.2% | 96,455 | +0.3% | 0.00% | 0.0% |
| Q4 2014 | $903,000 | +20.9% | 96,152 | -1.2% | 0.00% | 0.0% |
| Q3 2014 | $747,000 | -13.3% | 97,327 | +1.4% | 0.00% | 0.0% |
| Q2 2014 | $862,000 | +171.1% | 95,943 | +61.2% | 0.00% | – |
| Q1 2014 | $318,000 | +116.3% | 59,502 | +1.7% | 0.00% | – |
| Q4 2013 | $147,000 | -8.1% | 58,487 | -0.6% | 0.00% | – |
| Q3 2013 | $160,000 | -20.4% | 58,819 | +5.8% | 0.00% | – |
| Q2 2013 | $201,000 | – | 55,572 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sageview Capital | 2,223,339 | $5,603,000 | 1.59% |
| Orbimed Advisors | 2,320,800 | $5,848,000 | 0.09% |
| F&C Asset Management plc | 1,854,808 | $4,665,000 | 0.06% |
| SPHERA FUNDS MANAGEMENT LTD. | 56,500 | $142,000 | 0.04% |
| Yakira Capital Management, Inc. | 11,957 | $30,000 | 0.03% |
| Spectrum Management Group, LLC | 10,000 | $25,000 | 0.02% |
| Weiss Multi-Strategy Advisers LLC | 41,152 | $104,000 | 0.00% |
| WOLVERINE ASSET MANAGEMENT LLC | 30,000 | $75,000 | 0.00% |
| PUTNAM INVESTMENTS LLC | 129,762 | $327,000 | 0.00% |
| Partnervest Advisory Services LLC | 220 | $1,000 | 0.00% |